Video Experimental Relacionado
Updated: Jul 20, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Síntesis orgánica orientada a objetivos y a la diversidad en el descubrimiento de fármacos
1Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA. sls@slsiris.harvard.edu
Science (New York, N.Y.)
|March 17, 2000
Resumen
Esta revisión explora la planificación sintética para el descubrimiento de fármacos. Destaca cómo la síntesis orientada a la diversidad ayuda a encontrar nuevos objetivos farmacológicos mediante la creación de moléculas complejas para perturbar las vías biológicas.
Área de la Ciencia:
- Química medicinal Química medicinal es el campo de la química medicinal.
- Química sintética de la química sintética.
- Descubrimiento de Drogas Descubrimiento de Drogas
Sus antecedentes:
- El descubrimiento moderno de fármacos con frecuencia detecta moléculas pequeñas en busca de blancos de proteínas.
- El análisis retrosintético es clave para la síntesis orientada al objetivo de las bibliotecas enfocadas.
- El cribado basado en la ruta ofrece un enfoque alternativo sin un objetivo predefinido.
Objetivo del estudio:
- Revisar los principios de planificación sintética para la síntesis orientada a la diversidad (DOS).
- Para ilustrar el papel de DOS en el avance del descubrimiento de fármacos.
- Para discutir cómo DOS puede identificar nuevos objetivos terapéuticos.
Principales métodos:
- Discusión del análisis retrosintético para la síntesis orientada al objetivo.
- Exploración del análisis de síntesis avanzada para la síntesis orientada a la diversidad.
- Principios de generación de moléculas pequeñas estructuralmente complejas y diversas.
Principales resultados:
- DOS permite la síntesis eficiente de diversas colecciones de moléculas pequeñas.
- Estas colecciones pueden perturbar varias vías biológicas relacionadas con enfermedades.
- DOS facilita la identificación de nuevos objetivos terapéuticos modulados por moléculas pequeñas.
Conclusiones:
- La planificación sintética es crucial tanto para el descubrimiento de fármacos orientado al objetivo como para el orientado a la diversidad.
- La síntesis orientada a la diversidad ofrece una poderosa estrategia para identificar nuevos objetivos farmacológicos y terapias.
- La evolución del análisis de vías sintéticas es vital para los futuros esfuerzos de descubrimiento de fármacos.
Videos de Conceptos Relacionados
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...